Kimiyo Tabata

900 total citations · 1 hit paper
12 papers, 665 citations indexed

About

Kimiyo Tabata is a scholar working on Oncology, Molecular Biology and Aquatic Science. According to data from OpenAlex, Kimiyo Tabata has authored 12 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Molecular Biology and 2 papers in Aquatic Science. Recurrent topics in Kimiyo Tabata's work include Cancer Immunotherapy and Biomarkers (4 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Fish Biology and Ecology Studies (2 papers). Kimiyo Tabata is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Fish Biology and Ecology Studies (2 papers). Kimiyo Tabata collaborates with scholars based in Japan, United States and United Kingdom. Kimiyo Tabata's co-authors include Junji Matsui, Yusaku Hori, Yu Kato, Yasuhiro Funahashi, Yoichi Ozawa, Jun‐ichi Ito, Kazuhiko Yamada, K. Nomoto, Takayuki Kimura and Sho Tachino and has published in prestigious journals such as PLoS ONE, Cancer Research and Annals of Oncology.

In The Last Decade

Kimiyo Tabata

11 papers receiving 659 citations

Hit Papers

Lenvatinib plus anti-PD-1 antibody combination treatment ... 2019 2026 2021 2023 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway
    2019 341 citations Yu Kato, Kimiyo Tabata et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimiyo Tabata Japan 7 365 234 166 158 149 12 665
Yusaku Hori Japan 7 369 1.0× 234 1.0× 169 1.0× 166 1.1× 154 1.0× 16 710
Antonio Cusmai Italy 11 292 0.8× 47 0.2× 52 0.3× 124 0.8× 138 0.9× 28 577
Jobst C. von Einem Germany 15 456 1.2× 116 0.5× 157 0.9× 178 1.1× 36 0.2× 33 659
S D'Emidio Italy 8 452 1.2× 90 0.4× 144 0.9× 267 1.7× 139 0.9× 14 781
N. Vardakis Greece 17 629 1.7× 108 0.5× 44 0.3× 416 2.6× 29 0.2× 33 762
Masao Hori Japan 14 241 0.7× 73 0.3× 79 0.5× 129 0.8× 19 0.1× 43 686
Chuyu Jing China 13 212 0.6× 89 0.4× 23 0.1× 79 0.5× 61 0.4× 23 432
Kyungsoo Jung South Korea 13 299 0.8× 43 0.2× 59 0.4× 400 2.5× 26 0.2× 20 663
Carmela Iglesias Spain 10 163 0.4× 291 1.2× 59 0.4× 108 0.7× 36 0.2× 38 840
Dohee Kwon South Korea 13 459 1.3× 26 0.1× 221 1.3× 218 1.4× 195 1.3× 21 711

Countries citing papers authored by Kimiyo Tabata

Since Specialization
Citations

This map shows the geographic impact of Kimiyo Tabata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimiyo Tabata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimiyo Tabata more than expected).

Fields of papers citing papers by Kimiyo Tabata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimiyo Tabata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimiyo Tabata. The network helps show where Kimiyo Tabata may publish in the future.

Co-authorship network of co-authors of Kimiyo Tabata

This figure shows the co-authorship network connecting the top 25 collaborators of Kimiyo Tabata. A scholar is included among the top collaborators of Kimiyo Tabata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimiyo Tabata. Kimiyo Tabata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kohsaka, Shinji, Shigehiro Yagishita, Toshihide Ueno, et al.. (2024). A molecular glue RBM39-degrader induces synthetic lethality in cancer cells with homologous recombination repair deficiency. npj Precision Oncology. 8(1). 117–117. 3 indexed citations
2.
Ito, Ken, Masayuki Yamaguchi, Taro Semba, et al.. (2023). Amelioration of Tumor-promoting Microenvironment via Vascular Remodeling and CAF Suppression Using E7130: Biomarker Analysis by Multimodal Imaging Modalities. Molecular Cancer Therapeutics. 23(2). 235–247. 1 indexed citations
3.
Niwa, Yuki, Kimiyo Tabata, Yuji Mano, et al.. (2023). Liposome-Encapsulated Eribulin Shows Enhanced Antitumor Activity over Eribulin for Combination Therapy with Anti–PD-1 Antibody. Molecular Cancer Therapeutics. 22(4). 499–510. 8 indexed citations
4.
Kato, Yu, Kimiyo Tabata, Takayuki Kimura, et al.. (2019). Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway. PLoS ONE. 14(2). e0212513–e0212513. 341 indexed citations breakdown →
5.
Semba, Taro, et al.. (2019). Abstract 4089: Antitumor activity of eribulin in combination with anti-PD1 antibody in a mouse syngeneic breast cancer model. Cancer Research. 79(13_Supplement). 4089–4089. 4 indexed citations
6.
Kimura, Takayuki, Yu Kato, Yoichi Ozawa, et al.. (2018). Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1‐6 hepatocellular carcinoma model. Cancer Science. 109(12). 3993–4002. 240 indexed citations
7.
Kato, Yu, Xiaoyi Bao, Kimiyo Tabata, et al.. (2016). Lenvatinib mesilate (LEN) enhanced antitumor activity of a PD-1 blockade agent by potentiating Th1 immune response. Annals of Oncology. 27. vi1–vi1. 33 indexed citations
8.
Kato, Yu, Kimiyo Tabata, Yusaku Hori, et al.. (2015). Abstract A92: Effects of lenvatinib on tumor-associated macrophages enhance antitumor activity of PD-1 signal inhibitors. Molecular Cancer Therapeutics. 14(12_Supplement_2). A92–A92. 13 indexed citations
9.
Ozawa, Yoichi, et al.. (2014). 36 Suppression of metastasis and improvement of drug distribution by eribulin mesylate. European Journal of Cancer. 50. 17–17. 1 indexed citations
10.
11.
Tabata, Kimiyo. (1986). Survival of three types of ayu fish Plecoglossus altivelis fry in sea water rearing. Medical Entomology and Zoology. 24. 29–34. 11 indexed citations
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yusaku Hori Breakdown of academic impact, for papers by Antonio Cusmai Breakdown of academic impact, for papers by Jobst C. von Einem Breakdown of academic impact, for papers by S D'Emidio Breakdown of academic impact, for papers by N. Vardakis Breakdown of academic impact, for papers by Masao Hori Breakdown of academic impact, for papers by Chuyu Jing Breakdown of academic impact, for papers by Kyungsoo Jung Breakdown of academic impact, for papers by Carmela Iglesias Breakdown of academic impact, for papers by Dohee Kwon
Rankless by CCL
2026